3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 2
1
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Breast
10
Genitourinary
9
Thoracic
8
Gastrointestinal
8
CNS
7
Head & Neck
5
Sarcoma
4
Lymphoid
2
Gynecologic
2
Endocrine
1
Dermatologic
1
Conditions
Sarcoma
2
Neoplasms
2
Chordoma
2
Carcinoma, Adenoid Cystic
1
Interventions
Radiotherapy
215
Cyclophosphamide
210
Doxorubicin
207
Temozolomide
181
Ifosfamide
121
Filgrastim
111
Etoposide
101
Imatinib Mesylate
99
Vincristine
92
Gemcitabine
89
Bevacizumab
83
Irinotecan
79
Magnetic Resonance Spectroscopy
78
pembrolizumab
75
Radiation
66
Carboplatin
65
pazopanib
60
Methotrexate
60
Nivolumab
58
Cisplatin
58
fludarabine phosphate
56
Peripheral Blood Stem Cell Transplantation
56
Specimen Handling
53
Docetaxel
50
Busulfan
48
Trabectedin
47
Biopsy
47
Melphalan
46
Surgical Procedures, Operative
44
Paclitaxel
44
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Interventional
×
Protons
×
Sarcoma
×
Clear all
NCT04946357
2026-04-06
EXTREM ION
University Hospital Heidelberg
Phase NA
Recruiting
42 enrolled
NCT01811394
2023-12-06
ISAC
Heidelberg University
Phase 2
Unknown
100 enrolled
NCT02838602
2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA
Recruiting
250 enrolled
NCT01182779
2010-08-17
HIT-1
Heidelberg University
Phase 3
Unknown
319 enrolled